Leukoencephalopathy With Vanishing White Matter: A Review
The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index.
Abstract
Vanishing white matter (VWM) is one of the most prevalent inherited childhood leukoencephalopathies, but this may affect people of all ages, including neonates and adults. It is a progressive disorder clinically dominated by cerebellar ataxia and in which minor stress conditions, such as fever or mild trauma, provoke major episodes of neurologic deterioration. Typical pathological findings include increasing white matter rarefaction and cystic degeneration, oligodendrocytosis with highly characteristic foamy oligodendrocytes, meager astrogliosis with dysmorphic astrocytes, and loss of oligodendrocytes by apoptosis. Vanishing white matter is caused by mutations in any of the genes encoding the 5 subunits of the eukaryotic translation initiation factor 2B (eIF2B), EIF2B1 through EIF2B5. eIF2B is a ubiquitously expressed protein complex that plays a crucial role in regulating the rate of protein synthesis. Vanishing white matter mutations reduce the activity of eIF2B and impair its function to couple protein synthesis to the cellular demands in basal conditions and during stress. Reduced eIF2B activity leads to sustained improper activation of the unfolded protein response, resulting in concomitant expression of proliferation, prosurvival, and proapoptotic downstream effectors. Consequently, VWM cells are constitutively predisposed and hyperreactive to stress. In view of the fact that VWM genes are housekeeping genes, it is surprising that the disease is primarily a leukoencephalopathy. The pathophysiology of selective glial vulnerability in VWM remains poorly understood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in EIF2B1-5 genes, encoding subunits of eIF2b, responsible for protein translation, lead to leukoencephalopathy with vanishing white matter characterized by progressive degeneration of white matter due to myelination failure and impairments in oligodendrocyte function (Bugiani et al., 2010).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Bugiani et al., 2010
Citations
Cites
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · cited 1×
“Some mRNAs are exempt from inhibition through specific features in their 5¶ untranslated regions (104).”
BackgroundRegulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,276
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,828
McCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889
ER stress and the unfolded protein response
Schröder, M., & Kaufman, R. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.056 · Cited by 1,747
Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α
Novoa, I., Zeng, H., Harding, H. P., & Ron, D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1011 · Cited by 1,386
Welch, W. J. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.4.1063 · Cited by 1,190
Lu, P. D., Harding, H. P., & Ron, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408003 · Cited by 1,006 · cited 3×
“Novoa I, Zeng H, Harding HP, et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha.”
BackgroundTranscriptional and Translational Control in the Mammalian Unfolded Protein Response
Harding, H. P., Calfon, M., Urano, F., Novoa, I., & Ron, D. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.011402.160624 · Cited by 918
Gene-Specific Regulation by General Translation Factors
Dever, T. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00642-6 · Cited by 719
Research works printed but not linked: 4
- 10.1097/63.6.618 · doi:10.1097/63.6.618
- Van, 1999, Phenotypic variation in eukoencephalopathy with vanishing white matter, Reply from the authors. Neurology, 53, 1373
- Macchi, 1968, Su d un caso di leucopatia spongio-cavitaria, Acta Neurol, 24, 565
- Hinnebusch AG . Mechanism and regulation of initiation methionyl-tRNA binding to ribosomes. In: Sonenberg N Hershey JWB Mathews MB , eds. Translational Control of Gene expression . Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000:185–243
Cited by
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Eukaryotic Initiation Factor 2 Phosphorylation and Translational Control in Metabolism
Baird, T. D., & Wek, R. C. (2012) · Advances in Nutrition · doi:10.3945/an.112.002113 · Cited by 469
Oligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
“Microscopically, the affected white matter shows lack of myelin, myelin vacuolation, cystic changes, and only rarely loss of myelin with macrophages, arguing against demyelination [29].”
BackgroundInfluentialSelf-citationVanishing white matter disease
van der Knaap, M. S., Pronk, J. C., & Scheper, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70440-9 · Cited by 324
Self-citationRNA-binding proteins in Mendelian disease
Castello, A., Fischer, B., Hentze, M. W., & Preiss, T. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.01.004 · Cited by 255
Translation deregulation in human disease
Tahmasebi, S., Khoutorsky, A., Mathews, M. B., & Sonenberg, N. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0034-x · Cited by 255
Regulation of mRNA Translation in Neurons—A Matter of Life and Death
Kapur, M., Monaghan, C. E., & Ackerman, S. L. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.057 · Cited by 203
Astrocytes are central in the pathomechanisms of vanishing white matter
Dooves, S., Bugiani, M., Postma, N. L., Polder, E., Land, N., Horan, S. T., van Deijk, A.-L. F., van de Kreeke, A., Jacobs, G., Vuong, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83908 · Cited by 162
Self-citationDefective Glial Maturation in Vanishing White Matter Disease
Bugiani, M., Boor, I., van Kollenburg, B., Postma, N., Polder, E., van Berkel, C., van Kesteren, R. E., Windrem, M. S., Hol, E. M., Scheper, G. C., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318203ae74 · Cited by 137
Self-citationStructural basis for eIF2B inhibition in integrated stress response
Kashiwagi, K., Yokoyama, T., Nishimoto, M., Takahashi, M., Sakamoto, A., Yonemochi, M., Shirouzu, M., & Ito, T. (2019) · Science · doi:10.1126/science.aaw4104 · Cited by 126
Vanishing white matter: deregulated integrated stress response as therapy target
Abbink, T. E. M., Wisse, L. E., Jaku, E., Thiecke, M. J., Voltolini‐González, D., Fritsen, H., Bobeldijk, S., ter Braak, T. J., Polder, E., Postma, N. L., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50826 · Cited by 123
Self-citationAlzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
Pimenova, A. A., Herbinet, M., Gupta, I., Machlovi, S. I., Bowles, K. R., Marcora, E., & Goate, A. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105217 · Cited by 120
“impairments in oligodendrocyte function (Bugiani et al., 2010).”
Borck, G., Hög, F., Dentici, M. L., Tan, P. L., Sowada, N., Medeira, A., Gueneau, L., Thiele, H., Kousi, M., Lepri, F. R., et al. (2015) · Genome Research · doi:10.1101/gr.176925.114 · Cited by 117
Fine, A. S., Nemeth, C. L., Kaufman, M. L., & Fatemi, A. S. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9292-y · Cited by 115
Vanishing white matter: a leukodystrophy due to astrocytic dysfunction
Bugiani, M., Vuong, C., Breur, M., & van der Knaap, M. S. (2018) · Brain Pathology · doi:10.1111/bpa.12606 · Cited by 109
Self-citationBugiani, M., Postma, N., Polder, E., Dieleman, N., Scheffer, P. G., Sim, F. J., van der Knaap, M. S., & Boor, I. (2013) · Brain · doi:10.1093/brain/aws320 · Cited by 106
Self-citationBorck, G., Shin, B., Stiller, B., Mimouni-Bloch, A., Thiele, H., Kim, J.-R., Thakur, M., Skinner, C. D., Aschenbach, L., Smirin‐Yosef, P., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.005 · Cited by 96
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): A misdiagnosed disease entity
Sundal, C., Lash, J., Aasly, J. O., Øygarden, S., Roeber, S., Kretzschman, H., Garbern, J. Y., Tselis, A. C., Rademakers, R., Dickson, D. W., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.006 · Cited by 93
Novel mechanisms of eIF2B action and regulation by eIF2α phosphorylation
Bogorad, A. M., Lin, K. Y., & Marintchev, A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx845 · Cited by 89
Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders
Volpi, V. G., Touvier, T., & D’Antonio, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00162 · Cited by 80
Jiao, Y., Fu, Z., Li, Y., Meng, L., & Liu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s185459 · Cited by 70
Belgrad, J., Pace, R. D., & Fields, R. D. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1066-19.2019 · Cited by 68
Heterogeneity of white matter astrocytes in the human brain
Bugiani, M., Plug, B. C., Man, J. H. K., Breur, M., & van der Knaap, M. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02391-3 · Cited by 64
Self-citationWhite, R., Gonsior, C., Bauer, N. M., Krämer-Albers, E.-M., Luhmann, H. J., & Trotter, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235010 · Cited by 61
Dey, S., Savant, S. S., Teske, B. F., Hatzoglou, M., Calkhoven, C. F., & Wek, R. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351783 · Cited by 60
Dooves, S., Bugiani, M., Wisse, L. E., Abbink, T. E. M., van der Knaap, M. S., & Heine, V. M. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12411 · Cited by 60
Self-citationRaini, G., Sharet, R., Herrero, M., Atzmon, A., Shenoy, A., Geiger, T., & Elroy‐Stein, O. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14024 · Cited by 59
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Lanciotti, A., Brignone, M., Bertini, E., Petrucci, T., Aloisi, F., & Ambrosini, E. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0118-1 · Cited by 56
Cuadrado, E., Jansen, M. H., Anink, J. J., Filippis, L. D., Vescovi, A. L., Watts, C. K. W., Aronica, E., Hol, E. M., & Kuijpers, T. W. (2013) · Brain · doi:10.1093/brain/aws321 · Cited by 56
Unfolded protein response in myelin disorders
Lin, W., & Stone, S. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.266903 · Cited by 55
Peña, L. D. M., Jiang, Y., Schoch, K., Spillmann, R. C., Walley, N., Stong, N., Horn, S. R. G.-V., Sullivan, J. A., McConkie‐Rosell, A., Kansagra, S. M., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.128 · Cited by 54
Lin, Y., Pang, X., Huang, G., Jamison, S., Fang, J., Harding, H. P., Ron, D., & Lin, W. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1373-14.2014 · Cited by 53
Lin, Y., Huang, G., Jamison, S., Li, J., Harding, H. P., Ron, D., & Lin, W. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.009 · Cited by 52
eIF2B and the Integrated Stress Response: A Structural and Mechanistic View
Marintchev, A., & Ito, T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00132 · Cited by 52
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
Abu-Rub, M., & Miller, R. H. (2018) · Brain Sciences · doi:10.3390/brainsci8060111 · Cited by 50
Translational control in aging and neurodegeneration
Skariah, G., & Todd, P. K. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1628 · Cited by 45
Extensive Use of RNA-Binding Proteins inDrosophilaSensory Neuron Dendrite Morphogenesis
Olesnicky, E. C., Killian, D. J., Garcia, E., Morton, M. C., Rathjen, A. R., Sola, I., & Gavis, E. R. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.009795 · Cited by 44
Hamatani, M., Jingami, N., Tsurusaki, Y., Shimada, S., Shimojima, K. Y., Asada‐Utsugi, M., Yoshinaga, K., Uemura, N., Yamashita, H., Uemura, K., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.64 · Cited by 41
Leukoencephalopathies Associated with Macrocephaly
Renaud, D. L. (2012) · Seminars in Neurology · doi:10.1055/s-0032-1306384 · Cited by 40
Haas, M., Ngo, L., Li, S., Schleich, S., Qu, Z., Vanyai, H. K., Cullen, H. D., Cardona‐Alberich, A., Gladwyn-Ng, I. E., Pagnamenta, A. T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.090 · Cited by 39
Zhou, L., Li, P., Chen, N., Dai, L., Gao, K., Liu, Y., Shen, L., Wang, J., Jiang, Y., & Wu, Y. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13107 · Cited by 39
Axonal abnormalities in vanishing white matter.
Klok, M. D., Bugiani, M., de Vries, S. I., Gerritsen, W., Breur, M., van der Sluis, S., Heine, V. M., Kole, M. H. P., Baron, W., & van der Knaap, M. S. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.540 · Cited by 38
“White matter astrocytes and oligodendrocytes are selectively affected.(11,14,15,22) Recent studies indicate that astrocyte dysfunction is primary and oligodendrocyte dysfunction secondary.”
BackgroundSelf-citationAberrant expression and regulatory network of splicing factor-SRSF3 in tumors
Che, Y., & Fu, L. (2020) · Journal of Cancer · doi:10.7150/jca.42645 · Cited by 38
Astrocyte–Oligodendrocyte–Microglia Crosstalk in Astrocytopathies
de Waard, D. M., & Bugiani, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.608073 · Cited by 38
Self-citationInsights into the Architecture of the eIF2Bα/β/δ Regulatory Subcomplex
Bogorad, A. M., Xia, B., Sandor, D. G., Mamonov, A. B., Cafarella, T. M., Jehle, S., Vajda, S., Kozakov, D., & Marintchev, A. (2014) · Biochemistry · doi:10.1021/bi500346u · Cited by 36
Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter
Schiffmann, R., Fogli, A., van der Knaap, M. S., Boespflug‐Tanguy, O., Pagon, R. A., Bird, T. D., Dolan, C. R., Stephens, K., & Adam, M. P. (2010) · Pure Amsterdam UMC · Cited by 36
Brain connexins in demyelinating diseases: Therapeutic potential of glial targets
Cotrina, M. L., & Nedergaard, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.003 · Cited by 33
The Role of PERK in Understanding Development of Neurodegenerative Diseases
Smedley, G. D., Walker, K. E., & Yuan, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158146 · Cited by 29
Cabilly, Y., Barbi, M., Geva, M., Marom, L., Chetrit, D., Ehrlich, M., & Elroy‐Stein, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046715 · Cited by 29
Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response
Keefe, M. D., Soderholm, H. E., Shih, H., Stevenson, T. J., Glaittli, K. A., Bowles, D. M., Scholl, E. A., Colby, S., Merchant, S. S., Hsu, E. W., et al. (2020) · eLife · doi:10.7554/elife.56319 · Cited by 29
Gat‐Viks, I., Geiger, T., Barbi, M., Raini, G., & Elroy‐Stein, O. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13142 · Cited by 29
Hodgson, R. E., Varanda, B. A., Ashe, M., Allen, K. E., & Campbell, S. G. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-08-0538 · Cited by 29
Crystal structure of eIF 2B and insights into eIF 2– eIF 2B interactions
Kashiwagi, K., Ito, T., & Yokoyama, S. (2016) · FEBS Journal · doi:10.1111/febs.13896 · Cited by 29
A reliable computational workflow for the selection of optimal screening libraries
Gilad, Y., Nadassy, K., & Senderowitz, H. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0108-0 · Cited by 26
Vanishing White Matter Disease in a Spanish Population
Turón‐Viñas, E., Pineda, M., Cusí, V., López‐Laso, E., Pozo, R. L.-D., Gutiérrez-Solana, L. G., Moreno, D. C., Sierra-Córcoles, C., Olabarrieta-Hoyos, N., Madruga‐Garrido, M., et al. (2014) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s13540 · Cited by 24
Wei, C., Qin, Q., Chen, F., Zhou, A., Wang, F., Zuo, X., Chen, R., Lyu, J., & Jia, J. (2019) · BMC Neurology · doi:10.1186/s12883-019-1429-9 · Cited by 24
van der Knaap, M. S., Bugiani, M., & Abbink, T. E. M. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00015-6 · Cited by 22
Self-citationEarly-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene
Köhler, C., Heyer, C. M., Hoffjan, S., Stemmler, S., Lücke, T., Thiels, C., Kohlschütter, A., Löbel, U., Horváth, R., Kleinle, S., et al. (2015) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2015.06.005 · Cited by 23
Wortham, N. C., & Proud, C. G. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0204-z · Cited by 21
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation
Ghezzi, L., Scarpini, E. A., Rango, M., Arighi, A., Bassi, M. T., Tenderini, E., Riz, M. A. D., Jacini, F., Fumagalli, G., Pietroboni, A. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182749edc · Cited by 21
Zhang, H., Dai, L., Chen, N., Zang, L., Leng, X., Du, L. L., Wang, J., Jiang, Y., Zhang, F., Wu, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118001 · Cited by 21
Calame, D. G., Hainlen, M. K., Takacs, D. S., Ferrante, L., Pence, K., Emrick, L., & Chao, H. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000539 · Cited by 20
Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair
Lotun, A., Gessler, D. J., & Gao, G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661928 · Cited by 20
Borck, G., Hög, F., Dentici, M. L., Tan, P. L., Sowada, N., Medeira, A., Gueneau, L., Holger, T., Kousi, M., Lepri, F. R., et al. (2015) · Europe PMC (PubMed Central) · Cited by 18
Marom, L., Ulitsky, I., Cabilly, Y., Shamir, R., & Elroy‐Stein, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026992 · Cited by 17
Differential Diagnosis of White Matter Lesions: Nonvascular Causes—Part II
Weidauer, S., Nichtweiß, M., & Hattingen, E. (2014) · Clinical Neuroradiology · doi:10.1007/s00062-013-0267-1 · Cited by 17
Differential imaging of atypical demyelinating lesions of the central nervous system
Paoletti, M., Muzic, S. I., Marchetti, F., Farina, L. M., Bastianello, S., & Pichiecchio, A. (2021) · La radiologia medica · doi:10.1007/s11547-021-01334-y · Cited by 17
The physiological role of the unfolded protein response in the nervous system
Wu, S., & Lin, W. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.393105 · Cited by 16
Piscopo, V. E. C., Chapleau, A., Blaszczyk, G. J., Sirois, J., You, Z., Soubannier, V., Chen, C. X. ‐., Bernard, G., Antel, J. P., & Durcan, T. M. (2024) · Glia · doi:10.1002/glia.24524 · Cited by 16
Donato, I. D., Dotti, M. T., & Federico, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141026 · Cited by 15
Microcephaly-Thin Corpus Callosum Syndrome Maps to 8q23.2-q24.12
Halevy, A., Basel‐Vanagaite, L., Shuper, A., Hellman-Aharony, S., Har‐Zahav, A., Birk, E., Maya, I., Kornreich, L., Inbar, D., Nürnberg, G., et al. (2012) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.03.014 · Cited by 15
Shimada, S., Shimojima, K. Y., Sangu, N., Hoshino, A., Hachiya, Y., Ohto, T., Hashi, Y., Nishida, K., Mitani, M., Kinjo, S., et al. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.03.003 · Cited by 15
Lanciotti, A., Brignone, M. S., Macioce, P., Visentin, S., & Ambrosini, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010274 · Cited by 14
Progressive Brain Disorders in Childhood
Pascual, J. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781107323704 · Cited by 14
Integrated Stress Response in Neuronal Pathology and in Health
Korneeva, N. L. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922140103 · Cited by 14
Wu, S., & Lin, W. (2023) · Glia · doi:10.1002/glia.24346 · Cited by 13
Vanishing White Matter Disease in French-Canadian Patients From Quebec
Robinson, M., Rossignol, E., Brais, B., Rouleau, G. A., Arbour, J.-F., & Bernard, G. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.05.006 · Cited by 13
Gene therapy for leukodystrophy: progress, challenges and opportunities
Aubourg, P. R. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1151352 · Cited by 12
Regional vulnerability of brain white matter in vanishing white matter
Man, J. H. K., van Gelder, C. A. G. H., Breur, M., Molenaar, D., Abbink, T. E. M., Altelaar, M. A. F., Bugiani, M., & van der Knaap, M. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01599-6 · Cited by 12
Self-citationDing, X. Q., Bley, A. E., Ohlenbusch, A., Kohlschütter, A., Fiehler, J., Zhu, W., & Lanfermann, H. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23517 · Cited by 12
Jorge, M. S., & Bugiani, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_9 · Cited by 11
Self-citationAdvances In the Diagnosis of Leukodystrophies
Osterman, B., Piana, R. L., & Bernard, G. (2012) · Future Neurology · doi:10.2217/fnl.12.52 · Cited by 11
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA
Bugiani, M., Abbink, T. E. M., Edridge, A. W. D., van der Hoek, L., Hillen, A. E. J., van Til, N. P., Hu‐A‐Ng, G. V., Breur, M., Aiach, K., Drevot, P., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51772 · Cited by 11
Self-citationThe spectrum of adult-onset heritable white-matter disorders
Helman, G., Venkateswaran, S., & Vanderver, A. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00043-0 · Cited by 11
Cortical Pathology in Vanishing White Matter
Man, J. H. K., van Gelder, C. A. G. H., Breur, M., Okkes, D., Molenaar, D., van der Sluis, S., Abbink, T. E. M., Altelaar, M. A. F., van der Knaap, M. S., & Bugiani, M. (2022) · Cells · doi:10.3390/cells11223581 · Cited by 11
Self-citationKulalert, W., Sadeeshkumar, H., Zhang, Y. K., Schroeder, F. C., & Kim, D. H. (2017) · Genetics · doi:10.1534/genetics.117.200568 · Cited by 11
Song, H., Haeri, S., Vogel, H. S., van der Knaap, M. S., & van Haren, K. P. (2017) · Journal of Child Neurology · doi:10.1177/0883073817712588 · Cited by 11
Correlation Between Genotype and Age of Onset in Leukoencephalopathy With Vanishing White Matter
Deng, J., Zhou, L., Zhang, J., Chang, X., Jiang, Y., Wang, J., & Wu, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.729777 · Cited by 10
Zhou, L., Zhang, H., Chen, N., Zhang, Z., Liu, M., Dai, L., Wang, J., Jiang, Y., & Wu, Y. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8851-6 · Cited by 10
Tan, W., Gilmore, E. C., & Baris, H. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00018-5 · Cited by 10
Khorrami, M., Khorram, E., Yaghini, O., Rezaei, M., Hejazifar, A., Iravani, O., Yazdani, V., Riahinezhad, M., & Kheirollahi, M. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01810-0 · Cited by 9
Ren, Y., Yu, X., Chen, B., Tang, H., Niu, S., Wang, X., Pan, H., & Zhang, Z. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06011-0 · Cited by 9
Böck, D., Revers, I. M., Bomhof, A. S. J., Hillen, A. E. J., Boeijink, C., Kissling, L., Egli, S., Moreno-Mateos, M. A., van der Knaap, M. S., van Til, N. P., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.009 · Cited by 9
Leukodystrophies — much more than just diseases of myelin
van der Knaap, M. S., & Bugiani, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0093-9 · Cited by 9
Self-citationVanishing white matter disease with different faces
Güngör, G., Güngör, O., Çakmaklı, S., Genç, H. M., İnce, H., Yeşil, G., Dilber, C., & Aydın, K. (2019) · Child s Nervous System · doi:10.1007/s00381-019-04334-6 · Cited by 9
Gui, M., He, M., & Qin, L. (2024) · BMC Neurology · doi:10.1186/s12883-024-03721-0 · Cited by 9
Tian, Y., Liu, Q., Zhou, Y., Chen, X.-Y., Pan, Y., Xu, H., & Yang, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.901452 · Cited by 8
Xu, L., Zhong, M., Yang, Y., Wang, M., An, N., Xu, X., Zhu, Y., Li, Z., Chen, H., Zhao, R., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05710-4 · Cited by 8
Metadata
- Authors
- Bugiani, M., Boor, I., Powers, J. M., Scheper, G. C., & van der Knaap, M. S.
- Affiliations
- University of Rochester Medicine (US)
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 69
- Issue
- 10
- Pages
- 987-996
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2163139716
- Cited by
- 189
- References
- 109
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 16 · 2023: 12 · 2022: 9 · 2021: 13 · 2020: 12 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 6 · 2015: 9 · 2014: 17 · 2013: 10 · 2012: 17
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Funders
- ZonMw (9120.6002)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- vanishing white matter disease, leukoencephalopathy, eIF2B, oligodendrocyte apoptosis, cerebellar ataxia, unfolded protein response, stress-induced neurodegeneration, cystic degeneration
- MeSH terms
- Glycine, Humans, Nerve Fibers, Myelinated, Eukaryotic Initiation Factor-2B, Leukoencephalopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.